Green Laser Vaporizes Enlarged Prostates

The GreenLight HPS (High Performance System), made by Laserscope (San Jose, CA, USA), is a 532 nanometer wavelength green surgical laser designed to support the treatment of a range of soft tissue applications, including benign prostatic hyperplasia (BPH), bladder tumors, strictures, and lesions. Major benefits of the GreenLight HPS include a high power, low divergence laser beam allowing for precise and rapid tissue vaporization over a wide range of working distances, anatomy configurations, and tissue compositions; and a new delivery device design that eliminates backscatter, protecting vital tissue structures and providing higher efficiency vaporization.

Features include plug-and-play operation that auto-adjusts line voltage, an air cooled design and small form factor for use with standard utilities in a wide range of office and hospital settings, a voice-alert system, a touch-activated screen display that allows for easy adjustments of power and mode settings, as well as a number of pre-programmed settings for complete freedom during procedures.

The GreenLight HPS is an integral part of Laserscope's new GreenLight SurgiSuite, a solution designed to meet the needs of office-based surgical facilities for photo-selective vaporization (PVP) and other surgical procedures.

We are especially excited about the new GreenLight HPS, said Eric Reuter, president and CEO of Laserscope. "Customers wanted faster treatment speeds, better visibility, and for the product to operate using standard electrical service. We believe we have addressed these preferences and that this product will exceed customer expectations.

Half of all men over the age of 50 will develop BPH, a non-cancerous enlargement of the prostate that restricts urine flow. By the time men reach their 70s or 80s, 80% will experience urinary symptoms.


Related Links:
Laserscope